StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.18+0.01 (+0.85%)

Close on Nov 16, 2026Market cap $85.31MP/E –Yield –

InflaRx total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

InflaRx's total debt was €2.15M at Jun 30, 2022. For fiscal 2021 it was €0.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021€0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2022Jun 30, 2022€2.15M–
Q4 FY2021Dec 31, 2021€0–

More InflaRx figures

See a number that looks wrong?